Atlas Trials

Unresectable Gallbladder Carcinoma

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Unresectable Gallbladder Carcinoma

RecordFirmDate
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers (NCT03768414)SWOG Cancer Research Network2019-02-07
Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer (NCT03257761)University of Southern California2018-02-07
Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery (NCT02520141)M.D. Anderson Cancer Center2015-12-29
Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors (NCT02495896)University of Southern California2015-09-03
Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers (NCT02392637)M.D. Anderson Cancer Center2015-04-02
MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery (NCT01425879)National Cancer Institute (NCI)2011-04-01
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma (NCT01093222)National Cancer Institute (NCI)2010-04-01

Track Unresectable Gallbladder Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.